Click Here for 5% Off Your First Aladdin Purchase!

Oleic acid - ≥99% (HPLC), high purity , CAS No.112-80-1

  • Moligand™
  • ≥99%(HPLC)
Item Number
O108485
Grouped product items
SKUSizeAvailabilityPrice Qty
O108485-1ml
1ml
In stock
$11.90
O108485-5ml
5ml
In stock
$42.90
O108485-25ml
25ml
In stock
$157.90
O108485-100ml
100ml
In stock
$567.90
View related series
Carbonyl compound carboxylic acid

Basic Description

Synonymsoleic acid|112-80-1|cis-9-Octadecenoic acid|oleate|Elaidoic acid|cis-Oleic acid|Wecoline OO|Vopcolene 27|Glycon wo|(Z)-Octadec-9-enoic acid|Glycon RO|Oelsauere|Pamolyn 100|Groco 5l|Groco 2|Groco 4|Groco 6|Tego-oleic 130|Emersol 211|9Z-Octadecenoic acid|Me
Specifications & PurityMoligand™, ≥99%(HPLC)
Biochemical and Physiological MechanismsOleic acid is known to improve immune function and health. Dietary supplement of this fatty acid contributes to the reduction in cholesterol levels, atherogenesis risk, blood pressure, and host versus graft response. Oleic acid has been proven to benefit
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
Product Description

Oleic Acid, a monounsaturated fatty acid originally derived from Olea europaea, has been shown to be an anti-proliferative agent. This compound has also been reported to promote neuronal differentiation in murine cell cultures. Mechanistic studies suggest that these Oleic Acid effects are mediated by PPARβ. Furthermore, Oleic Acid has demonstrated the ability to stimulate an increase in secretion of collagen I, TGF-β secretion, and extracellular signal-regulated kinase1/2. Oleic Acid is an activator of PKC and CaMKII.
An anti-proliferative agent and activator of PKC and CaMKII

Application
Oleic acid has been used: to study the effects of fatty acids on gastric cancer (GC);to induce lipid droplet formation in cell culture;as an additive in the magnetorheological fluid preparation;Oleic acid may be used in the preparation of 10-hydroxy octadecanoic acid and methyl ester of the 10-hydroxy octadecanoic acid.

Associated Targets

DRD1 Tclin D(1A) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ESR1 Tclin Estrogen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FFAR4 Tchem Free fatty acid receptor 4 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH3 Tclin Histamine H3 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FABP4 Tchem Fatty acid-binding protein, adipocyte 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FAAH Tchem Fatty-acid amide hydrolase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A2 Tclin Sodium-dependent noradrenaline transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A3 Tclin Sodium-dependent dopamine transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TOP1 Tclin DNA topoisomerase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TERT Tchem Telomerase reverse transcriptase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SOAT1 Tchem Sterol O-acyltransferase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TRPV2 Tchem Transient receptor potential cation channel subfamily V member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PGR Tclin Progesterone receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PLK1 Tchem Serine/threonine-protein kinase PLK1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

RBP4 Tchem Retinol-binding protein 4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE3A Tclin cGMP-inhibited 3',5'-cyclic phosphodiesterase A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4A Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS2 Tclin Prostaglandin G/H synthase 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP19A1 Tclin Aromatase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KDR Tclin Vascular endothelial growth factor receptor 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

APEX1 Tchem DNA-(apurinic or apyrimidinic site) lyase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ACHE Tclin Acetylcholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2A Tclin Alpha-2A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAOA Tclin Amine oxidase [flavin-containing] A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TBXA2R Tclin Thromboxane A2 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

F2 Tclin Prothrombin 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ATM Tchem Serine-protein kinase ATM 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PPARA Tclin Peroxisome proliferator-activated receptor alpha 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PPARD Tchem Peroxisome proliferator-activated receptor delta 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PPARG Tclin Peroxisome proliferator-activated receptor gamma 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KDM4A Tchem Lysine-specific demethylase 4A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Pubchem Sid488189838
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488189838
IUPAC Name (Z)-octadec-9-enoic acid
INCHI InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-
InChi Key ZQPPMHVWECSIRJ-KTKRTIGZSA-N
Canonical SMILES CCCCCCCCC=CCCCCCCCC(=O)O
Isomeric SMILES CCCCCCCC/C=C\CCCCCCCC(=O)O
WGK Germany 1
RTECS RG2275000
PubChem CID 445639
Molecular Weight 282.46
Beilstein 1726542

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

18 results found

Lot NumberCertificate TypeDateItem
K2208594Certificate of AnalysisAug 23, 2024 O108485
K2208593Certificate of AnalysisAug 23, 2024 O108485
K2208494Certificate of AnalysisAug 23, 2024 O108485
D2417401Certificate of AnalysisMar 28, 2024 O108485
D2417400Certificate of AnalysisMar 28, 2024 O108485
E2206027Certificate of AnalysisFeb 22, 2024 O108485
F2308155Certificate of AnalysisMay 27, 2023 O108485
F2308156Certificate of AnalysisMay 27, 2023 O108485
F2308157Certificate of AnalysisMay 27, 2023 O108485
F2308159Certificate of AnalysisMay 27, 2023 O108485
F2308462Certificate of AnalysisMay 27, 2023 O108485
F2308463Certificate of AnalysisMay 27, 2023 O108485
F2308464Certificate of AnalysisMay 27, 2023 O108485
F2308466Certificate of AnalysisMay 27, 2023 O108485
K2208496Certificate of AnalysisAug 08, 2022 O108485
E2206026Certificate of AnalysisMar 25, 2022 O108485
E2206025Certificate of AnalysisMar 25, 2022 O108485
E2206021Certificate of AnalysisMar 25, 2022 O108485

more

Chemical and Physical Properties

SolubilitySoluble in ethanol (>25 mg/ml), ether, acetone, chloroform, DMF (100 mg/ml), DMSO (100 mg/ml), and PBS (pH 7.2) (<100 μg/ml).
SensitivityLight, Air and Heat sensitive
Refractive Index1.459
Flash Point(°F)>235.4 °F
Flash Point(°C)113 °C
Boil Point(°C)194-195°C/1.2mmHg
Melt Point(°C)13-14°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 1
RTECS RG2275000
Merck Index 6828

Related Documents

Alternative Products

References

1. .  (1990-11-01)  Oleic acid stimulation of apolipoprotein B secretion..  Nutrition reviews,  48  ((11)): (419-421).  [PMID:2080046]
2. R Valjakka-Koskela,J Hirvonen,J Mönkkönen,J Kiesvaara,S Antila,L Lehtonen,A Urtti.  (2000-10-18)  Transdermal delivery of levosimendan..  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,  11  ((4)): (343-350).  [PMID:11033078]
3. Hilda A Ayala-Bravo,David Quintanar-Guerrero,Aarti Naik,Yogeshvar N Kalia,José M Cornejo-Bravo,Adriana Ganem-Quintanar.  (2003-09-02)  Effects of sucrose oleate and sucrose laureate on in vivo human stratum corneum permeability..  Pharmaceutical research,  20  ((8)): (1267-1273).  [PMID:12948025]
4. Y Min,K Ghebremeskel,C Lowy,B Thomas,M A Crawford.  (2003-11-25)  Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes..  Diabetologia,  47  ((1)): (75-81).  [PMID:14634727]
5. Aaron P Russell,Emmanuel Somm,Richard Debigaré,Oliver Hartley,Denis Richard,Giacomo Gastaldi,Astrid Melotti,Annie Michaud,Jean-Paul Giacobino,Patrick Muzzin,Pierre LeBlanc,François Maltais.  (2004-12-17)  COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibers..  Journal of cardiopulmonary rehabilitation,  24  ((5)): (332-339).  [PMID:15602154]
6. Mandeep Bajaj,Swangjit Suraamornkul,Anthony Romanelli,Gary W Cline,Lawrence J Mandarino,Gerald I Shulman,Ralph A DeFronzo.  (2005-10-27)  Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients..  Diabetes,  54  ((11)): (3148-3153).  [PMID:16249438]
7. Justin I Odegaard,Roberto R Ricardo-Gonzalez,Alex Red Eagle,Divya Vats,Christine R Morel,Matthew H Goforth,Vidya Subramanian,Lata Mukundan,Anthony W Ferrante,Ajay Chawla.  (2008-06-05)  Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance..  Cell metabolism,  ((6)): (496-507).  [PMID:18522831]
8. C Carrillo,M del Ma Cavia,S Alonso-Torre.  (2012-11-21)  Role of oleic acid in immune system; mechanism of action; a review..  Nutricion hospitalaria,  27  ((4)): (978-990).  [PMID:23165533]
9. Adriana Soto-Guzman,Socrates Villegas-Comonfort,Pedro Cortes-Reynosa,Eduardo Perez Salazar.  (2013-01-22)  Role of arachidonic acid metabolism in Stat5 activation induced by oleic acid in MDA-MB-231 breast cancer cells..  Prostaglandins, leukotrienes, and essential fatty acids,  88  ((3)): (243-249).  [PMID:23332799]
10. Bum Han Ryu,Eunjin Jang,Hansol Ju,T Doohun Kim.  (2013-01-22)  A novel method for the preparation of a neurotoxic complex..  Analytical biochemistry,  435  ((2)): (137-139).  [PMID:23333268]
11. C Carrillo,Ma Del M Cavia,S R Alonso-Torre.  (2013-04-17)  Antitumor effect of oleic acid; mechanisms of action: a review..  Nutricion hospitalaria,  27  ((6)): (1860-1865).  [PMID:23588432]
12. James C S Ho,Petter Storm,Anna Rydström,Ben Bowen,Fredrik Alsin,Louise Sullivan,Inès Ambite,K H Mok,Trent Northen,Catharina Svanborg.  (2013-05-01)  Lipids as tumoricidal components of human α-lactalbumin made lethal to tumor cells (HAMLET): unique and shared effects on signaling and death..  The Journal of biological chemistry,  288  ((24)): (17460-17471).  [PMID:23629662]
13. Ying Liu,Zhanjun Jia,Shanshan Liu,Maicy Downton,Gang Liu,Yaomin Du,Tianxin Yang.  (2013-08-16)  Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice..  American journal of physiology. Renal physiology,  305  ((11)): (F1555-F1562).  [PMID:23946292]
14. Mika Hilvo,Stephan Gade,Tuulia Hyötyläinen,Valentina Nekljudova,Tuulikki Seppänen-Laakso,Marko Sysi-Aho,Michael Untch,Jens Huober,Gunter von Minckwitz,Carsten Denkert,Matej Orešič,Sibylle Loibl.  (2013-10-12)  Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients..  International journal of cancer,  134  ((7)): (1725-1733).  [PMID:24114462]
15. Eun-Jung Park,Ah Young Lee,Seung-Hee Chang,Kyeong-Nam Yu,Jae-Ho Kim,Myung-Haing Cho.  (2013-10-15)  Role of p53 in the cellular response following oleic acid accumulation in Chang liver cells..  Toxicology letters,  224  ((1)): (114-120).  [PMID:24120424]
16. Jinmi Lee,Seok-Woo Hong,Se Eun Park,Eun-Jung Rhee,Cheol-Young Park,Ki-Won Oh,Sung-Woo Park,Won-Young Lee.  (2014-01-22)  Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism..  Cell stress & chaperones,  19  ((5)): (649-656).  [PMID:24446069]
17. Valerio Pazienza,Michela Borghesan,Tommaso Mazza,Fareeba Sheedfar,Concetta Panebianco,Roger Williams,Gianluigi Mazzoccoli,Angelo Andriulli,Tomoko Nakanishi,Manlio Vinciguerra.  (2014-01-30)  SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation..  Aging,  ((1)): (35-47).  [PMID:24473773]
18. Gregory C Henderson,Nicholas P Evans,Robert W Grange,Marc A Tuazon.  (2014-02-15)  Compared with that of MUFA, a high dietary intake of n-3 PUFA does not reduce the degree of pathology in mdx mice..  The British journal of nutrition,  111  ((10)): (1791-1800).  [PMID:24524266]
19. Elizabeth Cocks,Oya Alpar,Satyanarayana Somavarapu,David Greenleaf.  (2014-03-22)  Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery..  Drug development and industrial pharmacy,  41  ((3)): (522-528).  [PMID:24650006]
20. Arunima Chaudhuri,Amitabha Chattopadhyay.  (2014-05-08)  Lipid binding specificity of bovine α-lactalbumin: a multidimensional approach..  Biochimica et biophysica acta,  1838  ((8)): (2078-2086).  [PMID:24802274]
21. Suzanne M Caliph,Fried W Faassen,Christopher J H Porter.  (2014-05-14)  The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol..  The Journal of pharmacy and pharmacology,  66  ((10)): (1377-1387).  [PMID:24821499]
22. Abdul Bari,Naveen Chella,Krishna Sanka,Nalini R Shastri,Prakash V Diwan.  (2014-08-05)  Improved anti-diabetic activity of glibenclamide using oral self nano emulsifying powder..  Journal of microencapsulation,  32  ((1)): (54-60).  [PMID:25090596]
23. Eleonora Dellera,Maria Cristina Bonferoni,Giuseppina Sandri,Silvia Rossi,Franca Ferrari,Claudia Del Fante,Cesare Perotti,Pietro Grisoli,Carla Caramella.  (2014-08-17)  Development of chitosan oleate ionic micelles loaded with silver sulfadiazine to be associated with platelet lysate for application in wound healing..  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,  88  ((3)): (643-650).  [PMID:25128852]
24. Paola Mura,Marco Bragagni,Natascia Mennini,Marzia Cirri,Francesca Maestrelli.  (2014-09-10)  Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin..  International journal of pharmaceutics,  475  ((1-2)): (306-314).  [PMID:25194352]
25. Konstanze Steiner,Bruno Hagenbuch,Daniel R Dietrich.  (2014-09-15)  Molecular cloning and functional characterization of a rainbow trout liver Oatp..  Toxicology and applied pharmacology,  280  ((3)): (534-542).  [PMID:25218291]
26. Cédric Montigny,Paulette Decottignies,Pierre Le Maréchal,Pierre Capy,Maike Bublitz,Claus Olesen,Jesper Vuust Møller,Poul Nissen,Marc le Maire.  (2014-10-11)  S-palmitoylation and s-oleoylation of rabbit and pig sarcolipin..  The Journal of biological chemistry,  289  ((49)): (33850-33861).  [PMID:25301946]
27. Jilite Wang,Masaya Shimada,Yukina Kato,Mio Kusada,Satoshi Nagaoka.  (2014-11-07)  Cholesterol-lowering effect of rice bran protein containing bile acid-binding proteins..  Bioscience, biotechnology, and biochemistry,  79  ((3)): (456-461).  [PMID:25374002]
28. Pablo J Giraudi,Varenka J Barbero Becerra,Veronica Marin,Norberto C Chavez-Tapia,Claudio Tiribelli,Natalia Rosso.  (2014-12-24)  The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation..  Experimental and molecular pathology,  98  ((1)): (85-92).  [PMID:25533546]
29. Motoko Sasaki,Masami Yoshimura-Miyakoshi,Yasunori Sato,Yasuni Nakanuma.  (2015-01-02)  A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis..  Journal of gastroenterology,  50  ((9)): (984-995).  [PMID:25552342]
30. Marta Estrader,Alberto López-Ortega,Igor V Golosovsky,Sònia Estradé,Alejandro G Roca,German Salazar-Alvarez,Lluís López-Conesa,Dina Tobia,Elin Winkler,José D Ardisson,Waldemar A A Macedo,Andreas Morphis,Marianna Vasilakaki,Kalliopi N Trohidou,Arsen Gukasov,Isabelle Mirebeau,O L Makarova,Roberto D Zysler,Francesca Peiró,Maria Dolors Baró,Lennart Bergström,Josep Nogués.  (2015-01-21)  Origin of the large dispersion of magnetic properties in nanostructured oxides: Fe(x)O/Fe3O4 nanoparticles as a case study..  Nanoscale,  ((7)): (3002-3015).  [PMID:25600147]
31. C Hochfellner,D Evangelopoulos,M Zloh,A Wube,J D Guzman,T D McHugh,O Kunert,S Bhakta,F Bucar.  (2015-01-22)  Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine..  Journal of applied microbiology,  118  ((4)): (864-872).  [PMID:25604161]
32. Mohamad Navab,Arnab Chattopadhyay,Greg Hough,David Meriwether,Spencer I Fogelman,Alan C Wagner,Victor Grijalva,Feng Su,G M Anantharamaiah,Lin H Hwang,Kym F Faull,Srinivasa T Reddy,Alan M Fogelman.  (2015-02-04)  Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis..  Journal of lipid research,  56  ((4)): (871-887).  [PMID:25646365]
33. Liliya Vinarova,Zahari Vinarov,Borislava Damyanova,Slavka Tcholakova,Nikolai Denkov,Simeon Stoyanov.  (2015-03-17)  Mechanisms of cholesterol and saturated fatty acid lowering by Quillaja saponaria extract, studied by in vitro digestion model..  Food & function,  ((4)): (1319-1330).  [PMID:25773645]
34. Michael A Boles,Dmitri V Talapin.  (2015-03-17)  Many-body effects in nanocrystal superlattices: departure from sphere packing explains stability of binary phases..  Journal of the American Chemical Society,  137  ((13)): (4494-4502).  [PMID:25773648]
35. Paul A Turner,Yi Tang,Stephen J Weiss,Amol V Janorkar.  (2015-03-18)  Three-dimensional spheroid cell model of in vitro adipocyte inflammation..  Tissue engineering. Part A,  21  ((11-12)): (1837-1847).  [PMID:25781458]
36. Achyut Khire,Pradeep Vavia.  (2015-03-20)  Bioavailability, bioequivalence, and in vitro-in vivo correlation of oxybutynin transdermal patch in rabbits..  Drug delivery and translational research,  ((2)): (105-115).  [PMID:25786724]
37. Yongsoon Park,Yoo-Sin Park,Seok Hyeon Kim,Dong Hoon Oh,Yong-Chon Park.  (2015-04-01)  Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea..  Annals of nutrition & metabolism,  66  ((2-3)): (141-148).  [PMID:25824637]
38. Monalisa Pal,Anirban Kundu,Rupali Rakshit,Kalyan Mandal.  (2015-04-14)  Ligand-induced evolution of intrinsic fluorescence and catalytic activity from cobalt ferrite nanoparticles..  Chemphyschem : a European journal of chemical physics and physical chemistry,  16  ((8)): (1627-1634).  [PMID:25867626]
39. Jean-Philippe Lanoix,Anne J Lenaerts,Eric L Nuermberger.  (2015-06-04)  Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis..  Disease models & mechanisms,  ((6)): (603-610).  [PMID:26035868]
40. Karen J Kieser,Cara C Boutte,Jemila C Kester,Christina E Baer,Amy K Barczak,Xavier Meniche,Michael C Chao,E Hesper Rego,Christopher M Sassetti,Sarah M Fortune,Eric J Rubin.  (2015-06-27)  Phosphorylation of the Peptidoglycan Synthase PonA1 Governs the Rate of Polar Elongation in Mycobacteria..  PLoS pathogens,  11  ((6)): (e1005010-e1005010).  [PMID:26114871]
41. L Jordaens,M Arias-Alvarez,I Pintelon,S Thys,S Valckx,Y Dezhkam,P E J Bols,J L M R Leroy.  (2015-06-30)  Elevated non-esterified fatty acid concentrations hamper bovine oviductal epithelial cell physiology in three different in vitro culture systems..  Theriogenology,  84  ((6)): (899-910).  [PMID:26119475]
42. Xiaobing Yang,Guojie Jin,Yandan Wang,Hongwei Shen,Zongbao K Zhao.  (2015-07-15)  Lipid production on free fatty acids by oleaginous yeasts under non-growth conditions..  Bioresource technology,  193  (557-562).  [PMID:26159379]
43. Varenka J Barbero-Becerra,Pablo J Giraudi,Norberto C Chávez-Tapia,Misael Uribe,Claudio Tiribelli,Natalia Rosso.  (2015-07-19)  The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH..  Toxicology in vitro : an international journal published in association with BIBRA,  29  ((7)): (1753-1758).  [PMID:26187275]
44. Mohammed Sattar,Jonathan Hadgraft,Majella E Lane.  (2015-07-22)  Preparation, characterization and buccal permeation of naratriptan..  International journal of pharmaceutics,  493  ((1-2)): (146-151).  [PMID:26196276]
45. Ram Jee Sharma,Ramesh C Gupta,Arvind Kumar Bansal,Inder Pal Singh.  (2015-07-23)  Metabolite Fingerprinting of Eugenia jambolana Fruit Pulp Extracts using NMR, HPLC-PDA-MS, GC-MS, MALDI-TOF-MS and ESI-MS/MS Spectrometry..  Natural product communications,  10  ((6)): (969-976).  [PMID:26197529]
46. Xiaoqian Ge,Lining Sun,Binbin Ma,Di Jin,Liang Dong,Liyi Shi,Nan Li,Haige Chen,Wei Huang.  (2015-07-30)  Simultaneous realization of Hg(2+) sensing, magnetic resonance imaging and upconversion luminescence in vitro and in vivo bioimaging based on hollow mesoporous silica coated UCNPs and ruthenium complex..  Nanoscale,  ((33)): (13877-13887).  [PMID:26219919]
47. Maha M Eissa,Riham M El-Moslemany,Alyaa A Ramadan,Eglal I Amer,Mervat Z El-Azzouni,Labiba K El-Khordagui.  (2015-11-18)  Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study..  PloS one,  10  ((11)): (e0141788-e0141788).  [PMID:26574746]
48. Violeta I Gallardo-Montejano,Geetu Saxena,Christine M Kusminski,Chaofeng Yang,John L McAfee,Lisa Hahner,Kathleen Hoch,William Dubinsky,Vihang A Narkar,Perry E Bickel.  (2016-08-25)  Nuclear Perilipin 5 integrates lipid droplet lipolysis with PGC-1α/SIRT1-dependent transcriptional regulation of mitochondrial function..  Nature communications,  (12723-12723).  [PMID:27554864]
49. Mehmet Boğa,Abdulselam Ertaş,Mustafa Abdullah Yılmaz,Murat Kızıl,Bircan Çeken,Nesrin Haşimi,Tuğba Yılmaz Özden,Serpil Demirci,İsmail Yener,Özcan Deveci.  (2016-12-17)  UHPLC-ESI-MS/MS and GC-MS Analyses on Phenolic, Fatty Acid and Essential Oil of.  Iranian journal of pharmaceutical research : IJPR,  15  ((3)): (393-405).  [PMID:27980574]
50. Leslie S Hamachi,Haoran Yang,Ilan Jen-La Plante,Natalie Saenz,Kevin Qian,Michael P Campos,Gregory T Cleveland,Iva Rreza,Aisha Oza,Willem Walravens,Emory M Chan,Zeger Hens,Andrew C Crowther,Jonathan S Owen.  (2019-08-02)  Precursor reaction kinetics control compositional grading and size of CdSe1-x S x nanocrystal heterostructures..  Chemical science,  10  ((26)): (6539-6552).  [PMID:31367306]
51. Marta Corzo-Martínez,Celia Bañares,Alejandro Díaz,Luis Vázquez,Guillermo Reglero,Carlos F Torres.  (2020-01-15)  In vitro digestibility and bioaccessibility of lipid-based delivery systems obtained via enzymatic glycerolysis: a case study of rosemary extract bioaccessibility..  Food & function,  11  ((1)): (813-823).  [PMID:31932815]
52. Pegah Moradi Khaniabadi,Daryoush Shahbazi-Gahrouei,Azlan Abdul Aziz,Mohammed Ali Dheyab,Bita Moradi Khaniabadi,Baharak Mehrdel,Mahmood Subhi Jameel.  (2020-06-26)  Trastuzumab conjugated porphyrin-superparamagnetic iron oxide nanoparticle: A potential PTT-MRI bimodal agent for herceptin positive breast cancer..  Photodiagnosis and photodynamic therapy,  31  (101896-101896).  [PMID:32585402]
53. Ryan J Schulze,Eugene W Krueger,Shaun G Weller,Katherine M Johnson,Carol A Casey,Micah B Schott,Mark A McNiven.  (2020-12-09)  Direct lysosome-based autophagy of lipid droplets in hepatocytes..  Proceedings of the National Academy of Sciences of the United States of America,  117  ((51)): (32443-32452).  [PMID:33288726]
54. Nasa Sinnott-Armstrong,Isabel S Sousa,Samantha Laber,Elizabeth Rendina-Ruedy,Simon E Nitter Dankel,Teresa Ferreira,Gunnar Mellgren,David Karasik,Manuel Rivas,Jonathan Pritchard,Anyonya R Guntur,Roger D Cox,Cecilia M Lindgren,Hans Hauner,Richard Sallari,Clifford J Rosen,Yi-Hsiang Hsu,Eric S Lander,Douglas P Kiel,Melina Claussnitzer.  (2021-01-30)  A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density..  Cell metabolism,  33  ((3)): (615-628).  [PMID:33513366]
55. Mehmet Oguz Gok,Natalie Ortiz Speer,W Mike Henne,Jonathan R Friedman.  (2021-11-25)  ER-localized phosphatidylethanolamine synthase plays a conserved role in lipid droplet formation..  Molecular biology of the cell,  33  ((1)): (ar11-ar11).  [PMID:34818062]
56. .  ()  The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice..      [PMID:25550469]
57. Li-Fen Chiang,Ruey-An Doong.  (2014-02-22)  Cu-TiO2 nanorods with enhanced ultraviolet- and visible-light photoactivity for bisphenol A degradation..  Journal of hazardous materials,  277  (84-92).  [PMID:24556011]

Solution Calculators